KOLOA, Hawaii — Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. KOLOA ...
KULR Technology Group shares were 10% higher, at $2.64, after the company entered into a collaboration with the Scripps Research Institute's Baran Lab to continue development of a pyrolytic carbon ...
Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes.